Main Page Article Search E-Lerts™ Newsletter: Current E-Lerts™ Newsletter Archives E-Lerts™ Newsletter Recipes Archives Defeat Diabetes® E-Lerts™ Newsletter Subscribe Defeat Diabetes ® News by Daniel H. Rasolt Books You Can Use™ Subscribe to Defeat Diabetes Foundation Mailings
About Diabetes Body Care Children Complications Defeat Diabetes Foundation Drugs    » ACE Inhibitor    » Actos    » Alternative Medicine    » Aspirin    » Avandia    » Byetta    » Drugs    » Exenatide    » Glargine    » Glucophage    » Insulin    » Januvia    » Lantus    » Liraglutide    » Metformin    » Recall    » Research    » Rosiglitazone    » Self-Management    » Statins    » Sulfonylureas    » Victoza Elderly E-Lerts™ Governments & Organizations Health & Fitness Insulin MADDCAP™ Mr. Diabetes® Nutrition Obesity Other Diseases Pregnancy Research Risks Self-Management Supplements Type 1 Warning Signs

 

 

 

     

Drugs

Search our News Articles Archives for diabetes and health news. Search by word or phrase.  The latest article will appear first.

Search For:  

Search in all categories / subcategories
Search in current category / subcategory

Diabetes Drug Also Reduces Inflammation Posted: Saturday, November 05, 2011

A GLP-1 drug prescribed to help patients with type 2 diabetes improve blood-sugar control also has a powerful anti-inflammatory effect, and the effect was observed within 2 hours following a single dose.

Pyridoxamine May Slow Early Diabetic Nephropathy Posted: Saturday, November 05, 2011

Pyridoxamine (vitamin B6) is known to be an effective scavenger of reactive oxygen species and a potent inhibitor of advanced glycation end products. A new study demonstrated the benefits for patients with Type 2 diabetes.

NIH Urges You To Make a Plan To Prevent Diabetes, Complications Posted: Wednesday, November 02, 2011

In observance of National Diabetes Month and World Diabetes Day on Nov. 14, the National Institutes of Health urges people to set goals and make plans to prevent diabetes and diabetes-related complications.

Diabetes Medication Compliance a Major U.S. Issue Posted: Sunday, October 23, 2011

We need to do a better job. Research by the New England Healthcare Institute shows that patients who don't take their medications as prescribed, cost the U.S. health care system an estimated $290 billion in avoidable medical spending each year.

FDA Approves Diabetes and Cholesterol-Lowering Drug Combo: Juvisync® Posted: Sunday, October 09, 2011

Known as Juvisync (Merck), the new medication combines sitagliptin (Januvia, Merck), a dipeptidyl peptidase-4 (DPP-4) inhibitor used for glycemia control, with the cholesterol-lowering simvastatin.

Diabetes Set To Soar As Kuwait Follows In US's Footsteps Posted: Thursday, October 06, 2011

"Diabetes has become an epidemic." This was the stark message delivered by American diabetes expert Andrew Mandell, also known as 'Mr. Diabetes®,' yesterday. Speaking at a press conference held at the American Embassy on the risks of diabetes and the various preventative measures that can be taken to reduce the incidence of the disease, Mandell, who has walked 10,030.3 miles along the borders of the US to raise awareness of diabetes, said that Kuwait is a "snapshot" of where the US stood in relation to the condition 40 or 50 years ago, and is mirroring similar patterns to those seen in the States.

Defeating Diabetes Requires Awareness, Right Choices Posted: Thursday, October 06, 2011

Defeating diabetes requires self-awareness and making the right choices, which are elements essential for Kuwait to combat the disease, said Executive Director for the Defeat Diabetes Foundation (DDF) Andrew Mandell on Wednesday. Speaking at a roundtable press meeting at the US Embassy, Mandell, also known as "Mr. Diabetes", told KUNA that building diabetes prevention habits were integral for such situations, affirming that such steps would "impact the disease" which is becoming an epidemic in Kuwait.

New First in Class Glucagon Antagonists Show Promise for Diabetes Posted: Sunday, September 25, 2011

New data on two investigational glucagon receptor antagonists suggest that this novel class of drugs has potential to be an effective treatment for type 2 diabetes.

Intensified Treatment with Basal Insulin Improves Control and Weight Loss Posted: Saturday, September 24, 2011

Adding insulin detemir to a treatment regimen of metformin and liraglutide improved glycemic control and led to sustained weight loss for up to 52 weeks in patients with type 2 diabetes.

EASD: Outpatient Test Discriminates MODY from Type 1 Diabetes Posted: Saturday, September 24, 2011

A measure of the postprandial ratio of urinary C-peptide to creatinine (UCPCR) can distinguish maturity-onset diabetes of the young (MODY) from type 1 diabetes mellitus, allowing some children who would otherwise be treated with insulin to receive oral antidiabetic agents alone.

 

 

 

 

 

 Costa Rica Travel Corp. will donate a portion of the proceeds to and is a sponsor of Defeat Diabetes Foundation.